![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61P 43/00 | |
A61K 45/06 | |||
A61K 31/4184 | |||
A61K 31/4439 | |||
A61K 31/4745 | |||
A61K 31/496 | |||
A61K 31/506 | |||
A61K 31/519 | |||
A61K 31/53 | |||
A61K 31/5377 | |||
A61P 35/00 |
(11) | Number of the document | 2976106 |
(13) | Kind of document | T |
(96) | European patent application number | 14715440.5 |
Date of filing the European patent application | 2014-03-19 | |
(97) | Date of publication of the European application | 2016-01-27 |
(45) | Date of publication and mention of the grant of the patent | 2021-04-14 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2014/059975 |
Date | 2014-03-19 |
(87) | Number | WO 2014/147573 |
Date | 2014-09-25 |
(30) | Number | Date | Country code |
201361804056 P | 2013-03-21 | US |
(72) |
CAPONIGRO, Giordano, US
STUART, Darrin, US
DE PARSEVAL, Laure, CH
|
(73) |
Array BioPharma Inc.,
3200 Walnut Street, Boulder, CO 80301,
US
|
(54) | COMBINATION THERAPY COMPRISING A B-RAF INHIBITOR AND A SECOND INHIBITOR |
COMBINATION THERAPY COMPRISING A B-RAF INHIBITOR AND A SECOND INHIBITOR |